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Background: Lipopolysaccharide (LPS)-triggered Toll-like receptor (TLR) 4-signalling belongs to the key innate
defence mechanisms upon infection with Gram-negative bacteria and triggers the subsequent activation of adaptive
immunity. There is an active crosstalk between TLR4-mediated and other signalling cascades to secure an effective
immune response, but also to prevent excessive inflammation. Many pathogens induce signalling cascades via
secreted factors that interfere with TLR signalling to modify and presumably escape the host response. In this context
heterotrimeric G proteins and their coupled receptors have been recognized as major cellular targets. Toxigenic
strains of Gram-negative Pasteurella multocida produce a toxin (PMT) that constitutively activates the heterotrimeric G
proteins Gαq, Gα13 and Gαi independently of G protein-coupled receptors through deamidation. PMT is known to
induce signalling events involved in cell proliferation, cell survival and cytoskeleton rearrangement.
Results: Here we show that the activation of heterotrimeric G proteins through PMT suppresses LPS-stimulated IL-
12p40 production and eventually impairs the T cell-activating ability of LPS-treated monocytes. This inhibition of
TLR4-induced IL-12p40 expression is mediated by Gαi-triggered signalling as well as by Gβγ-dependent activation of
PI3kinase and JNK.
Taken together we propose the following model: LPS stimulates TLR4-mediated activation of the NFĸB-pathway and
thereby the production of TNF-α, IL-6 and IL-12p40. PMT inhibits the production of IL-12p40 by Gαi-mediated
inhibition of adenylate cyclase and cAMP accumulation and by Gβγ-mediated activation of PI3kinase and JNK
activation.
Conclusions: On the basis of the experiments with PMT this study gives an example of a pathogen-induced
interaction between G protein-mediated and TLR4-triggered signalling and illustrates how a bacterial toxin is able to
interfere with the host’s immune response.
Keywords: Monocytes, Toll-like receptor 4, Heterotrimeric G proteins, Pasteurella multocida toxin, Interleukin-12, T
lymphocytes, Immune evasionBackground
Monocytes are professional antigen presenting cells and
carry out at least two important functions during infec-
tion. First of all they represent a barrier against patho-
gens through their antimicrobial activity and second they
support the initiation of adaptive immune responses.
The latter is exerted by the presentation of processed
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distribution, and reproduction in any mediummolecules to T lymphocytes, the expression of various
costimulatory proteins on the cell surface and the pro-
duction of cytokines [1,2]. To direct these functions dur-
ing an immune response, monocytes become activated
through binding of conserved microbial structures to
their respective pattern-recognition receptors (PRRs).
Within the group of PRRs, Toll like receptors (TLRs) play
a well-known role in the initiation of such immune
responses. Up to now, 10 functional TLRs have been
identified in humans [3]. Each TLR detects distinct
PAMPs derived from viruses, bacteria, mycobacteria,
fungi, and parasites [3]. Gram-negative bacteria aretral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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polysaccharide (LPS) that binds in complex with the
LPS-binding Protein (LBP) to a receptor complex of
TLR4, CD14 and an associated protein (MD-2) [4]. The
TLR4-mediated signalling cascades then modulate the
gene expression towards the production of a variety of
pro-inflammatory cytokines such as Interleukin (IL)-6,
Tumour necrosis factor (TNF)-α and IL-12 [5]. In
addition, these signalling events enhance the costimula-
tory function of monocytes [6]. However, this TLR4-
mediated induction of inflammation and activation of
adaptive immunity is actively targeted and modulated by
a variety of pathogens, presumably to impair the immune
response. At this, heterotrimeric G proteins play an im-
portant role. Bacterial toxins that act on heterotrimeric G
proteins such as Cholera Toxin (CT) of Vibrio cholerae,
heat-labile enterotoxin (LT) of enteropathic Escherichia
coli or Pertussis Toxin (Ptx) of Bordetella pertussis can
therefore alter LPS-induced cytokine release. This is
achieved by heterotrimeric G protein-mediated produc-
tion of cAMP which eventually results in an altered cyto-
kine release, most notably of IL-12, by human monocytic
cells. The molecular mechanism of the effect is however
only incompletely understood [7,8].
Another toxin that targets heterotrimeric G proteins is
produced by toxigenic strains of Gram-negative Pasteur-
ella multocida bacteria that can be isolated from chronic
respiratory infections in animals and from humans after
cat or dog bites [9]. Pasteurella multocida toxin (PMT) is
known to activate Gαq, Gαi and Gα13 [10-13] independ-
ently of a G protein-coupled receptor through deamida-
tion resulting in the constitutively activation of the α-
subunit and release of the βγ-subunit [14]. This leads to
the downstream activation of signalling events such as
phospholipase Cβ activation, induction of the mitogen-
activated protein (MAP) kinase pathways, the RhoA/Rho
kinase (ROCK) pathway and the Janus kinase (JAK)-sig-
nal transducers of transcription (STAT) pathway [15-18].
Additionally, PMTactivates Gαi, thus inhibiting adenylate
cyclase activity and cAMP accumulation [10].
In this study we investigated how the activation of het-
erotrimeric G proteins through PMT influences the
TLR4-mediated activation of human blood-derived
monocytes (hBDMs) and their ability to induce T cell
proliferation. Our data demonstrate that PMT modulates
TLR4-mediated cytokine production. This effect was
most pronounced for the release of IL-12p40, a cytokine
important for T cell activation. The suppression of IL-
12p40 release resulted in the inhibition of the T cell-
activating ability of LPS-activated hBDMs. This block
could be restored by adding IL-12-containing superna-
tants of LPS-stimulated hBDMs to the mixed lympho-
cyte reaction (MLR), showing that IL-12 was both,
necessary and sufficient. The toxin mediates thisinhibition of TLR4-induced IL-12p40 expression by Gαi-
mediated inhibition of adenylate cyclase and subsequent
cAMP accumulation in combination with a Gβγ-
mediated activation of PI3kinase and the MAP kinase
JNK. These findings give new insights into the modula-
tion of an immune response by a bacterial toxin and we
hypothesise that the decreased T cell activation results in
increased survival of the pathogen.
Results
PMT modulates LPS-triggered cytokine release of human
blood-derived monocytes
Antigen presenting cells regulate lymphocyte-mediated
immune responses through presentation of antigens to
lymphocytes via the major histocompatibility complex
(MHC) on their surface, costimulatory or co-inhibitory
signals that are delivered by ligands of the B7 family and
via the release of cytokines [19].
Our study aimed to clarify whether the LPS-induced
activation of hBDMs through TLR4 is modulated by the
heterotrimeric G protein activator PMT and whether the
toxin itself activates monocytes. We prestimulated
hBDMs with wildtype PMT (PMTwt) or the inactive mu-
tant PMTRBD, which contains the receptor binding do-
main (RBD) but lacks the C-terminal catalytic domain
(CD), for three hours, as the intracellularly-acting toxin
needs time to enter the cell and to translocate to the
cytoplasm [20]. LPS was then added in co-stimulated
samples for overnight incubation. The first experiments
addressed whether the expression of immune-relevant
ligands on monocytes was changed in the presence of
PMT compared to unstimulated or LPS-treated samples.
The surface expression of MHC II and the B7 family
members B7.1 (CD80), B7.2 (CD86), inducible co-
stimulator ligand (ICOS-L), programmed death-1 ligand
(PD-L1), programmed death-2 ligand (PD-L2), B7-H3
and B7-H4 were determined by FACS analysis. The
results demonstrate that PMTwt alone activates mono-
cytes only to a small extent as can be seen by the nearly
unchanged expression patterns compared to the un-
stimulated samples. Samples that had been treated with
LPS and PMTwt showed an increase in the level of CD80
when compared to the LPS-treated control and a smaller
increase was also detectable for B7H3, B7H4 and MHC2
(Figure 1A). Stimulation with the inactive PMTRBD did
not change the expression pattern of untreated and LPS-
treated hBDMs at all (data not shown). We therefore
conclude that PMTwt by itself is unable to stimulate
monocyte activation and that it only marginally increases
monocyte activation induced by LPS.
Next, we investigated, whether PMT modulates the in-
flammatory response of monocytes by inducing or inhi-
biting their ability to release cytokines. We stimulated




















































































































































Monocytes:     unst. PMT










  -           -             -           -           -           -            -            -             + 













Figure 1 (See legend on next page.)
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Figure 1 PMT-mediated modulation of LPS-activated monocytes. A. Monocytes were stimulated with PMTwt (1 μg/ml, 3 h prestimulation)
and/or LPS (30 ng/ml; over night stimulation) or left unstimulated. The expression levels of surface markers were analysed by flow cytometry
using fluorescently labelled antibodies against CD80, CD86, B7H3, B7H4, ICOSL, MHC2, PDL-1 and PDL-2. The results are presented as overlays
which were produced using Weasel v2.5 software. Shown is one representative result from three independent experiments. B. Cells were
stimulated as described in A. As additional control inactive PMTRBD (1 μg/ml, 3 h prestimulation) was used. The release of TNF-α, IL-6, IL-10 and IL-
12p40 was measured by ELISA. Shown is the mean of three independent experiments (mean ± SD; n = 3) C. Monocytes were stimulated as
described in A, washed with media and used for MLR with 1x104 CD14+ hBDMs and 1x105 CD3+ alloreactive T cells. After three days of co-culture
proliferation of T cells was analysed by [3H]-thymidine incorporation and presented as counts per minute (cpm). D. Cells were stimulated and T
cell proliferation was analysed as described in C. To rescue the T cell-activating ability of LPS/PMT-treated monocytes, co-cultures were
supplemented with supernatant (Sn) of LPS-treated monocytes or recombinant IL-12. MLRs were performed in triplicates. Shown is the mean of
three independent experiments (mean ± SD; n = 3). Statistical significance was assessed by using student’s t test with *P < 0.05.
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sured the release of pro-inflammatory IL-6, TNF-α and
IL-12p40 and anti-inflammatory IL-10 by ELISA analyses
(Figure 1B). As expected, LPS-stimulated monocytes
released elevated levels of all four cytokines. PMTwt only
enhanced the secretion level of IL-6 in a statistically rele-
vant manner. While the toxin had a minor influence on
LPS-triggered TNF-α secretion and IL-10 production, it
elevated the LPS-induced IL-6 level considerably, but al-
most totally abrogated the IL-12p40 release of activated
cells. Since the truncated toxin again did not affect
hBDMs we assigned the observed modulation to the
catalytic function of the toxin and continued the studies
with PMTwt.
PMT attenuates T cell-activating ability of LPS-activated
monocytes
T cell activation by antigen presenting cells requires the
interaction between MHC complexes and T cell recep-
tors as well as the binding of costimulatory B7 molecules
to the CD28 receptor on T cells [21]. Additionally, IL-12
exerts a strong synergistic effect with the B7/CD28 inter-
action in inducing proliferation and cytokine production
in T cells [22].
As PMTwt only slightly elevated TLR4-mediated ex-
pression of costimulatory ligands on hBDMS (Figure 1A)
and almost totally prevented LPS-stimulated IL-12p40
production (Figure 1B), we asked whether the toxin
would affect T cell proliferation induced by the presence
of LPS-treated hBDMs. To this end we performed mixed
lymphocyte reactions with LPS- and/or PMTwt-stimu-
lated monocytes and allogeneic T cells. The quantification
of T cell proliferation after three days of co-culture
revealed that PMT-stimulated monocytes did not differ
significantly from unstimulated cells in mediating T cell
proliferation. However, the toxin strongly inhibited the
ability of LPS-stimulated hBDMs to activate T cell prolif-
eration (Figure 1C). This pronounced suppression of T
cell activation was reversed by adding recombinant IL-12
or supernatants from LPS-treated cells known to have a
high level of IL-12p40 (Figure 1B and D). We therefore
conclude that the suppressive influence of PMTwt onmonocyte-mediated T cell activation is due to a change in
cytokine release, and in particular caused by the abro-
gated IL-12p40 production.
PMT does not alter the cytokine release of LPS-activated
hBDMs via the cyclooxygenase (COX)-2/Prostaglandin E2
(PGE2) pathway
To identify the mechanism behind the PMT-modulated
cytokine secretion of LPS-activated hBDMs, we first
examined the COX/PGE2 pathway. The lipid mediator
PGE2 is a well-established immunomodulatory substance
which is produced during the immune response of anti-
gen presenting cells. PGE2 is known to be a potent in-
ducer of IL-10 and a strong inhibitor of IL-12
production [23,24]. COX proteins play a key role in the
synthesis of prostaglandins. Whereas COX-1 is constitu-
tively expressed and induces a basal level of PGE2, COX-
2 is specifically induced by inflammatory stimuli [25]. To
check whether PGE2 could be responsible for the PMT-
induced blockade of IL-12p40, we treated LPS-
stimulated hBDMs with increasing concentrations of re-
combinant PGE2 and quantified the release of cytokines.
Whereas there was no significant influence detectable on
IL-6 production, LPS-induced TNF-α and IL-12p40 se-
cretion were diminished by PGE2 (Figure 2A). We next
determined the mRNA level of COX-2 in LPS and/or
PMTwt-treated hBDMs to investigate whether PGE2
could be released in this setting. The performed quanti-
tative real-time PCRs showed that LPS and PMTwt both
triggered COX-2 gene transcription but that there was
no pronounced synergistic effect between PMT and LPS
(Figure 2B). To investigate whether the minor change in
COX-2 expression could explain the PMT-induced
change in cytokine release, we used various COX-2 inhi-
bitors. Neither SC560 nor Meloxicam or NS398 neutra-
lised the blockade of IL-12p40 production (Figure 2C) or
changed the pattern of released IL-6 and TNF-α (data
not shown). Mixed lymphocyte reactions additionally
revealed that the COX-2 inhibitors did not restore the T
cell-activating ability of LPS-treated monocytes after
PMTwt-stimulation (Figure 2D). Based on these data we
exclude a prominent impact of the COX2/PGE2 pathway
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hBDMs.
PMT-induced modulation of LPS-triggered IL-12 release
involves the Gαi/cAMP pathway
In order to characterize the PMT-induced signalling
pathway that modulates cytokine production of LPS-
activated monocytes, we next focused on the heterotri-
meric G protein Gαi that is directly activated by PMT
[10]. While the exact mechanism is still under investiga-
tion, it is commonly accepted that Gαi- and Gαs-
mediated alterations in intracellular cAMP metabolism
play a key role in modulating IL-12 production. At this,
GPCR ligands of adenylate cyclase-activator Gαs as well
as GPCR agonists of adenylate cyclase-inhibitor Gαi were
shown to decrease the capacity of antigen presenting cells
to produce IL-12 [8]. Whereas the connection of adenyl-
ate cyclase-activation and IL-12 decrease may be more
generally accepted, investigations with the Gαi-activator
mastoparan, the Gαi-inhibitor Ptx as well as studies using
Gαi-deficient mice clearly revealed an inhibitory effect of
this G protein on LPS-induced cytokine release in differ-
ent cells types, including human monocytes [26-28]. To
investigate the role of Gαi on the PMT-mediated manipu-
lation of TLR4 signalling we pre-treated LPS and/or
PMTwt-stimulated monocytes with Ptx or mastoparan.
The performed cytokine ELISAs show that neither Ptx
nor mastoparan significantly influenced IL-6 production
of unstimulated or stimulated cells. The alteration of
TNF-α was more influenced but statistically not signifi-
cant. The impact of Gαi was most pronounced on IL-
12p40. Mastoparan mimicked the inhibition of IL-12p40
and Ptx could almost fully restore the LPS-induced pro-
duction of IL-12p40 after toxin-treatment (Figure 3A).
To confirm that the Ptx-mediated reconstitution of IL-12
production is due to the influence of G proteins, we
included the B oligomer subunit of Ptx in our studies.
The Ptx B oligomer is the receptor binding domain but
can also initiate signal transduction pathways [29]. How-
ever, it does not play a role in the activation of G-protein
signalling that is initiated by the catalytic subunit. As it
exerted no influence on the PMT-mediated suppression
of IL-12p40 (Figure 3B), we assigned the Ptx effect to the
inhibition of Gαi.
Moreover, in mixed lymphocyte reactions using allor-
eactive T cells it was revealed that Ptx reconstituted the
PMTwt-blocked activation of T cells proliferation through
LPS-stimulated monocytes, while mastoparan/LPS-trea-
ted monocytes on the other hand were less activating
than cells treated with LPS only (Figure 3B). These data
implicate that the PMTwt-activated Gαi protein is respon-
sible for the abolishment of LPS-activated IL-12p40 re-
lease, while its impact on IL-6 and TNF-α is only
marginal.In order to further analyse the link between PMTwt-
activated Gαi and IL-12p40 suppression, we next concen-
trated on protein kinase A (PKA), as elevated cAMP
concentrations can result in PKA activation [30]. This
serine/threonine kinase mediates phosphorylation of
substrates and subsequently induces the transcription of
a variety of genes via the binding of transcription factors
such as CRE-binding protein (CREB) to the DNA bind-
ing motif cAMP-response element (CRE) present in the
promoter region of cAMP-regulated genes [31,32]. To
mimic the PMT-induced inhibition of PKA caused by an
inhibition of adenylate cyclase and cAMP accumulation,
we included the PKA-specific inhibitor H89 in our stud-
ies. As a control, we verified that the inhibitor was able
to block Ptx-induced IL-12p40 production (Figure 3C).
Compared to PMTwt, H89 did not totally abolish LPS-
induced IL-12p40 release but significantly diminished
the LPS-induced release of the cytokine (Figure 3C) and
as a consequence decreased the T cell-activating ability
of hBDMs (Figure 3D). These data indicate a prominent
role for PKA in the suppression of LPS-induced IL-
12p40 production.
PMT-activated JNK contributes to the suppression of IL-12
production
Next we investigated whether other known regulators of
IL-12p40 may contribute to the PMT-induced abolish-
ment of LPS-mediated IL-12p40 release. Mitogen acti-
vated protein kinases (MAP kinases) are described to
modulate IL-12 production in myeloid cells. Whereas
ERK (p42/44) and JNK were shown to inhibit IL-12p40
release [33,34], p38 is known as an inducer of IL-12p40
[35]. We therefore determined the activation status of
ERK, JNK and p38 after PMTwt treatment and the modu-
lation of LPS-activated MAP kinases. The performed
western blot analyses revealed that PMT, as expected,
neither significantly activated p38 nor modulated the
slight LPS-induced p38 phosphorylation. However, ERK
activation was enhanced after six hours of PMTwt treat-
ment and the LPS-mediated phosphorylation was se-
verely enhanced by the toxin. In addition, the low JNK
activation detectable after six hours of PMTwt and one
hour of LPS-treatment was strongly enhanced by simul-
taneous stimulation with both stimuli (Figure 4A). To
verify whether this observed activation of ERK and JNK
could account for the suppression of LPS-mediated IL-
12p40 production, we used specific MAP kinase inhibi-
tors. Monocytes were pre-treated with the MEK1 inhibi-
tor UO126 (upstream of ERK) or JNK inhibitor II and
stimulated with PMTwt and LPS. The blots in
Figure 4B show that 20 μM of UO 126 reduced LPS/
PMTwt-induced ERK phosphorylation to basal levels and
10 μM of JNK inhibitor II totally blocked the activation
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Figure 2 (See legend on next page.)
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Figure 2 Contribution of the COX-2/PGE2 pathway to the PMT-mediated modulation of LPS-activated monocytes. A. Monocytes were
stimulated overnight with LPS (30 ng/ml) and treated in parallel with PGE2 in increasing concentrations. Supernatants were used to quantify the
release of TNF-α, IL-6 and IL-12p40 by ELISA. Presented is the mean and standard deviation of three independent experiments. B. Cells were
stimulated with LPS (30 ng/ml; 1 h), PMTwt (1 μg/ml; 4 h) or PMTwt/LPS (4 h/1 h) or left unstimulated. RNA was extracted, cDNA was prepared and
used for quantitative PCR analysis with specific primers for COX2. The results are presented as relative expression to the reference gene (GAPDH).
Shown is one representative experiment with 10% standard error. C. Monocytes were pre-treated for 2 hours with the cox-inhibitors NS398
(3.8 μM), sc560 (6.3 μM) or meloxican (4.7 μM). Then cells were stimulated with PMTwt (1 μg/ml, 3 h prestimulation) and/or LPS (30 ng/ml; over
night stimulation). The release of IL-12p40 was measured by ELISA. Shown is the mean of three independent experiments (mean± SD; n = 3) D.
Monocytes were stimulated as described in C. After washing, the cells were used for MLR with 1x104 CD14+ hBDMs and 1x105 CD3+ alloreactive T
cells. After three days of co-culture, proliferation of T cells was analysed by [3H]-thymidine incorporation and presented as counts per minute
(cpm). Statistical significance was calculated by using student’s t test with *P < 0.05 and **P < 0.01.
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inhibition of ERK did not affect LPS-induced IL-12p40
release, the suppression of JNK restored LPS-induced
cytokine production (Figure 4C). Simultaneous inhibition
of JNK and Gαi activation through Ptx treatment abol-
ished the PMT effect (Figure 4C) and restored the T cell-
activating ability of LPS-treated cells after PMTwt-stimu-
lation (Figure 4D). These data indicate that PMT inhibits
LPS-mediated IL-12p40 expression via Gαi-mediated sig-
nalling and the activation of JNK.
PMT-stimulated JNK-activation involves PI3-kinase
Our next experiments addressed the question how PMT
activates JNK. Recent publications suggest PI3 kinase as
a mediator between Gαi-proteins and Ras/MAP kinase
activation [36,37]. Interestingly, PMT activates PI3-
kinase γ through dissociation of Gβγ subunits from the
Gαi subunit [38]. Here, we demonstrate by western blot
analysis that PMTwt induces the phosphorylation of the
PI3-kinase target Akt in primary monocytes (Figure 5A).
To check whether the activation of JNK depends on PI3-
kinase activation we blocked PI3 kinase using wortman-
nin and observed a reduction of JNK phosphorylation in
PMTwt- and most notably in LPS/PMTwt-stimulated cells
(Figure 5A, right section). Furthermore, the inhibition of
Gαi-activation by treatment with Ptx diminished the sti-
mulated Akt activation downstream of PI3 kinase and
impaired the activation of JNK (Figure 5A, middle sec-
tion). This suggests that PI3 kinase mediates PMTwt-sti-
mulated JNK activation and that the βγ subunits of Gαi
and other PMT-activated Gα proteins induce the activa-
tion of the kinase. ELISA experiments confirmed that
the inhibition of JNK activation through wortmannin
could reduce the PMT-mediated IL-12p40 suppression.
Finally, the inhibition of both, JNK and Gαi-mediated
signalling through Ptx, totally restored the LPS-induced
production of the cytokine (Figure 5B). Performed MLRs
confirmed the impact of the restored IL-12-production
on the T cell-proliferation (Figure 5C).
Taken together we propose the following model: LPS
stimulates TLR4-mediated activation of the NFĸB-
pathway and modulates the production of TNF-α, IL-6and IL-12p40. PMT inhibits the production of IL-12p40
through Gαi-mediated inhibition of adenylate cyclase
and cAMP accumulation as well as by PI3kinase/Akt
and JNK activation mediated by the dissociated Gβγ sub-
unit (Figure 6).
Discussion
Antigen presenting cells are crucial for the first-line host
defence and act as mediators between innate and adap-
tive immunity. One major pathway of these cells involves
TLR-mediated signalling events, which can detect and
react to extracellular as well as intracellular microbial
components [39,40]. To be effective, immune responses
need the crosstalk between TLR-mediated and other sig-
nalling cascades that play a role in immune responses or
other cellular pathways, respectively. These interactions
can have synergistic effects but can also antagonise
responses in order to prevent excessive inflammation. To
modify and presumably escape the host’s immune re-
sponse pathogens have developed various strategies to
interfere with signalling cascades of the host [41,42]. Be-
sides direct inhibition or modification of TLR signalling,
induction of alternative regulative or antagonistic en-
dogenous signalling cascades is another strategy in im-
mune evasion. Here, we investigated how the activation
of heterotrimeric G proteins through the bacterial toxin
PMT modulates TLR4-mediated activation of human
blood-derived monocytes and how this potentially affects
cells of the adaptive immune system such as T cells.
Our data on the expression of MHC and costimulatory
B7 family members show that PMT alone does not acti-
vate monocytes by itself and only slightly enhances LPS-
triggered cell activation. However, PMT is able to modu-
late the TLR4-mediated cytokine production of these
cells significantly leading to an almost complete block of
IL-12p40 production. Bioactive IL-12 is a potent activa-
tor of natural killer (NK) cell and T cells and, together
with the B7/CD28 interaction between antigen present-
ing cells and T cells, IL-12 has a strong synergistic effect
in inducing T cell proliferation [22,43]. Our data show
that due to the absence of IL-12, PMT suppresses T cell
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Figure 3 (See legend on next page.)
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Figure 3 Gαi-mediated modulation of LPS-induced IL-12 production. A. Monocytes were stimulated overnight with Pertussis toxin (Ptx;
200 ng/ml) or left unstimulated. The next day PMTwt (1 μg/ml) or mastoparan (20 μM) was added. After three hours LPS was added for overnight
incubation (30 ng/ml). The release of TNF-α, IL-6 and IL-12p40 were measured by ELISA. Shown is the mean of three independent experiments
(mean ± SD; n = 3). B.As additional control cells were treated with Ptx B oligomer and ELISAs were performed with collected supernatant.
(mean ± SD; n = 2) C. Monocytes were stimulated as described in A. After washing, co-cultures of CD14+ hBDMs and CD3+ alloreactive T cells were
prepared. After 3 days proliferation of T cells was analysed by [3H]-thymidine incorporation and presented as counts per minute (cpm), mean± SD;
n = 3. D. Cells were stimulated as followed: H89 (10 μM; 2 h pre-stimulation) and LPS (30 ng/ml) or Ptx (200 ng/ml) overnight, PMTwt (1 μg/ml, 3 h
pre-stimulation) and LPS overnight. Supernatants of cells were used for IL-12 ELISAs. The results are presented as mean± SD; n = 3. E. Equally
treated monocytes were used for MLRs with alloreactive T cells. Shown is the mean and standard deviation of three independent experiments.
Statistical significance was assessed by using student’s t test with *P < 0.05 and **P < 0.01.
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by adding IL-12-containing supernatants of LPS-
stimulated hBDMs or recombinant IL-12 to the mixed
lymphocyte reaction. Although IL-10 is a known sup-
pressor of IL-12 activity [44], a dominant role of IL-10
could be excluded, since PMT only slightly enhanced the
LPS-induced IL-10 production.
Bagley et al.. demonstrated that PMT also suppresses
LPS-stimulated IL-12 release of human macrophage-
derived dendritic cells and they speculate that this block-
ade is caused by Gαq-mediated Phospholipase C-β activa-
tion and subsequent intracellular calcium mobilization,
but they did not further investigate this [45]. For human
monocytes we suggest that PMT prevents TLR4-
mediated IL-12p40 production through Gαi- and βγ-
mediated signalling cascades, respectively. PMT activates
Gαi and thereby inhibits adenylate cyclase activity and
cAMP accumulation, independently of Gαq and Gα12/13
[10]. Our data point to Gαi signalling as the Gαi agonist
mastoparan mimicked the suppression of LPS-induced
IL-12p40 production. Recently it became clear that data
obtained from experiments using mastoparan have to be
interpreted with care as mastoparan can bind the toxic
lipid A portion of the LPS molecule [46]. Nevertheless, as
in our studies mastoparan only blocked LPS-stimulated
IL-12p40 production and did not block TLR4-mediated
IL-6 and TNF-α expression, we assign the result primarily
to Gαi-mediated signalling. Additionally, the Gαi-inhibi-
tor Pertussis toxin (Ptx) reversed the PMT-mediated
blockage of IL-12-release and restored the T cell-
activating ability of LPS-treated monocytes.
In the past it has been shown that both Gαi and Gαs,
although having opposite function and acting as negative
regulators for each other, are able to downregulate IL-12
production [8,47]. This suggests that alterations in intra-
cellular cAMP metabolism in general play a role in
modulating the IL-12 production. The molecular mech-
anism, however, is only poorly understood. Our data in-
dicate that Protein kinase A (PKA) is involved in the
PMT-mediated suppression of IL-12p40 production
induced by LPS. In our experiments the PKA-specific in-
hibitor H89 significantly diminished LPS-induced releaseof IL-12p40 and decreased the T cell-activating ability of
hBDMs. It thereby mimicked the PMT-induced effect on
monocytes at least to some extent. H89 totally blocked
Ptx-induced IL-12p40 production, demonstrating that
the Gαi-protein-inhibitor Ptx induces IL-12 via PKA.
Our experiments suggest that signalling mechanisms
directly dependent on Gαi account partially for the PMT-
triggered abrogation of LPS-induced IL-12p40 produc-
tion, but they also indicate that other pathways are
involved. Another signalling cascade connected to IL-12
production is the MAP kinase pathway, whereas ERK
(p42/44) and JNK are known inhibitors of IL-12 produc-
tion [35]. Our investigations demonstrate that simultan-
eous stimulation of the cells with PMT and LPS induced
a strong activation of JNK. Furthermore, inhibition of
JNK restored LPS-induced IL-12 production after PMT-
treatment. Although G proteins are known to activate the
MAP kinase cascade, the exact mechanism is not well
defined. However, a potential link to known PMT-
mediated signalling pathways comes from a publication
that showed the activation of this pathway was induced
by phospholipase C and protein kinase C [48]. These pro-
teins are known to be activated by PMT through Gαq ac-
tivation [16]. Additionally, βγ subunits dissociated from
their Gαi subunit were also identified as initiators of the
Ras/MAP kinase pathway [37,49]. Our experiments point
to Gαi proteins as well as their respective dissociated βγ
subunits as mediators of the PMT-stimulated JNK phos-
phorylation, as the Gαi inhibitor Ptx significantly dimin-
ished the PMT/LPS-induced activation of the kinase. It is
also possible that βγ subunits of other PMT-activated G
proteins may additionally be involved, as the inhibition of
Gβγ release through Ptx did not completely suppress
JNK activation. The possibility that βγ subunits of various
G proteins are involved has also been discussed previ-
ously by Preuss et al.. [38].
Kranenburg et al. claim from their experiments in
COS cells and fibroblasts that the missing link between
Gβγ and Ras/MAP kinase activation is PI3 kinase [37].
In addition, Lopez-Ilasaca et al. confirmed that overex-
pressed PI3 kinase activates MAP kinases [36,37]. Recent
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Figure 4 Involvement of MAPkinases in the modulation of LPS-induced IL-12 release. A. Monocytes were stimulated with PMTwt (1 μg/ml)
and/or LPS (30 ng/ml) for the indicated time points or left unstimulated. The cells were lysed and extracted with RIPA buffer as described under
Experimental procedures. Total amounts of p42/44, JNK and p38 and the phosphorylation levels of the MAP kinases was determined by
subsequent immunoblotting with specific antibodies (p42/44: Thr202/Tyr204 JNK: Thr183/Tyr185, p38: Thr180/Tyr182). Shown is one representative
blot from three. B. Cells were pre-treated for two hours with UO 126 or JNK inhibitor II (concentrations indicated) and then stimulated with PMTwt
(1 μg/ml, 4 h) and LPS (30 ng/ml, 1 h). Unstimulated cells were used as a control. Lysates of the cells were immunoblotted with antibodies
against p-p42/44, p42/44, p-c-Jun, c-Jun or actin. C. Cells were pre-treated with Ptx (200 ng/ml, overnight), UO 126 (10 μM, 2 h) or JNK inhibitor II
(20 μM, 2 h), followed by stimulation with PMTwt (1 μg/ml, 3 h pre-treatment) and LPS (30 ng/ml) overnight. The release of IL-12p40 was
measured by ELISA (mean ± SD; n = 2). D. Cells that were treated like described in C and used for MLR (1x104 CD14+ hBDMs, 1x105 CD3+
alloreactive T cells). After three days of co-culture proliferation of T cells was analysed by [3H]-thymidine incorporation and presented as counts
per minute (cpm). Results are given as mean± SD; n = 2. Statistical significance was calculated with a student’s t test with *P < 0.05 and **P < 0.01.
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firms the finding that the toxin mediates the phosphoryl-
ation of Akt, the target of PI3 kinase, also in primary
monocytes. The publication of La Sala et al. suggests that
the Gαi-protein activator C5a suppresses TLR4-mediated
IL-12 via the Akt pathway and JNK, but independently
of PI3 kinase [34]. We show here that in the case of
PMT-mediated Gβγ activation the PI3 kinase inhibitor
wortmannin diminished the activation of JNK, suggesting
that there is a possible link between MAP kinase activa-
tion and PI3 kinase/Akt.
Our data clearly show that inputs from Gαi protein-
mediated signalling pathways modulate TLR4-induced
signalling. Other authors even suggest a direct interaction
between TLR4 and Gαi. Solomon et al. demonstrated that
the LPS/LBP receptor CD14 co-immunoprecipitates with
various α subunits of the Gαi/Gαo family and that the
Gαi activator mastoparan inhibits LPS-induced IL-6 and
TNF-α production in human monocytes [28]. Another
report claims that Gαi itself is activated rapidly but
transiently by LPS through an unknown mechanism. In
a mouse model the authors showed that Ptx increased
the level of LPS-induced plasma inflammatory media-
tors, whereas mastoparan decreased the cytokine level
[26]. However, in these studies the influence of Gαi acti-
vation on IL-12p40 production as a downstream result
of these signalling events had not been investigated. Re-
cently, another report confirmed the hypothesis that
TLR ligands activate Gαi proteins in endothelial cells
[51]. It was shown that LPS stimulates PI3 kinase and
MAP kinase activation via Gαi, independently of the
TLR-induced MyD88-TRAF6 pathway. The authors
speculate that TLR2, 3 and 4 can also directly interact
with Gαi via their intracellular domains due to a con-
sensus motif for Gαi/0 binding (Figure 6). In our hands
LPS-stimulated Akt-activation could be diminished by
Ptx which supports the hypothesis of LPS-induced Gαi
activation. Regardless of whether PMT is the only Gαi
activator or whether the toxin additionally increases
the LPS-triggered Gαi activation, our data clearly
show that the PMT-induced Gαi-mediated signalling
interferes with and suppresses TLR4-induced IL-12p40
production.
Conclusion
In summary we show that PMT inhibits the TLR4-
mediated production of IL-12p40 at least in two ways.
First of all, PMT induces Gαi-mediated inhibition of ad-
enylate cyclase and cAMP accumulation. Furthermore,
PMT leads to a Gβγ-mediated activation of PI3kinase
and subsequent JNK activation mediated by Gαi and pre-
sumably other Gα subunits activated by PMT. These sig-
nalling cascades act specifically on the production of IL-
12p40 as they influence the LPS-stimulated TNF-αrelease only slightly and have no impact on IL-6 release.
Taken together our observations contribute to the under-
standing of the interaction between G protein-mediated
and TLR4-mediated signalling and show how a bacterial
toxin is able to manipulate monocytes which eventually
results in impaired T cell activation.Methods
Recombinant PMTwt and PMTRBD were kindly provided
by Dr. Joachim Orth and Prof. Dr. Dr. Klaus Aktories
from Freiburg. The TLR agonist LPS was provided by U.
Seydel (Borstel). The p44/42 inhibitor UO126, JNK in-
hibitor II, Pertussis toxin (full length and B oligomer
subunit), mastoparan and wortmannin were purchased
from Calbiochem. Recombinant IL-12 was obtained from
Immunotools.Preparation of monocytes
Monocytes were isolated from fresh blood or buffy coat
by density gradient centrifugation (Biocoll separating so-
lution 1.077 g/mL; Biochrom AG) and washed three
times with PBS. CD14 cells were positively selected by
magnetic-associated cell sorting (AutoMACS: program
possel; Miltenyi Biotec). Sorted cells were cultured in
RPMI 1640 medium (Biochrom AG) supplemented with
10% FBS (BioWest) and 1% penicillin and streptomycin
(PAA) at 37°C in a humidified atmosphere in the pres-
ence of 5% CO2.Mixed lymphocyte reaction (MLR)
T cells were obtained from fresh blood by positive selec-
tion with CD3-labelled magnetic beads and FcR blocking
reagent (AutoMACS: program possel; Miltenyi Biotec).
MLRs were performed in 96 well plates in allogeneic
settings: purified T cells (1x105) were co-cultured with
pre-treated and washed monocytes (1x104). Cells were
cultured for 3 days and exposed to [3H]-thymidine
(Amersham Pharmacia Biotech GmbH) during the last
6 h of culture. Thymidine uptake was measured using a
liquid scintillation counter.Flow cytometry (FACS)
Briefly, cells were washed with PBS/10% FBS, blocked for
30 min in PBS/10% FBS, and incubated with the corre-
sponding antibodies (anti-B7H3-PE, anti-B7H4-PE, anti-
PDL-1-APC, anti-PDL-2PE, anti-ICOSL-PE from
eBioscience anti-CD80-PE, anti-CD86-PE, anti-MHC2-
FITC from BD Pharmingen) in PBS/10% FBS for 1 h at
4°C. After three washes quantification was done by FACS
analysis using a BD FACSCanto workstation and BD
FACSDiva software (BD Biosciences). Overlays were pro-
duced using Weasel v2.5 software.
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Figure 5 Involvement of PI3kinase in JNK-activation. A. Monocytes were pre-treated with Ptx (overnight incubation, 200 ng/ml) or
wortmannin (2 h, 100 nM) and then stimulated with PMTwt (1 μg/ml, 4 h) and or LPS (30 ng/ml, 1 h). Whole-cell lysates were prepared, proteins
were separated by SDS-PAGE and p-JNK (Thr183/Tyr185), JNK, p-AKT (Thr308) and actin were detected using specific antibodies. Shown is one
representative western blot out of three. B. Cells were treated as described in A or stimulated with Ptx and wortmannin. Supernatants were
collected and IL-12p40 ELISAs were performed. Results are presented as mean± SD; n = 3. C. Monocytes were stimulated like described in B and
MLRs were performed. Results are given as mean± SD; n = 3. Statistical significance in B. and C. was calculated with a student’s t test with *P < 0.05
and **P < 0.01.
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Cell-free supernatants were harvested and analysed for
IL-6, IL-12p40, IL-10 and TNF-α by commercial avail-
able ELISA kits (OptEIA; BD).
Western blotting
After washing with PBS, cells were resuspended in RIPA
buffer (150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
1% Deoxycholat, 1 mM sodium fluoride, 25 mM Tris)
containing phosphatase inhibitors (PhosSTOP, Roche
Diagnostics) and incubated for 45 min at 4°C. After cen-
trifugation, lysates were used as whole-cell extracts. Sam-
ples were separated on 10% SDS-PAGE, transferred to
nitrocellulose and incubated with the relevant antibodies
(Cell Signaling Technology: p42/44, pThr202/Tyr204
p42/44, JNK, pThr183/Tyr185 JNK, p38, pThr180/
Tyr182 p38, pSer63 c-Jun, pThr 308 Akt, Actin) followedFigure 6 Proposed model of PMT-induced inhibition of LPS-stimulate
NFĸB-pathway and thereby the production of TNF-α, IL-6 and IL-12p40. PM
adenylate cyclase and cAMP accumulation and by Gβγ-mediated activation
receptor binding domain (RBD) and C-terminal catalytic domain (CD).by incubation with the respective HRP-coupled antibody
(Cell Signaling Technology) and detection by enhanced
chemiluminescence.
Reverse transcription-PCR
RNA was extracted with the “High pure RNA Isolation
Kit” (Roche). cDNA was prepared using ‘Reverse Aid
First Strand cDNA Synthesis Kit’ (Fermentas life sci-
ence). Aliquots of the cDNA were used for quantitative
PCR analysis with the ‘SYBR Green Rox mix’ (Thermo
Scientific) with the following primers: GAPDH, sense,
5′-acg gat ttg gct-3′,antisense, 5′-ttg acg gtg cca tgg aat
ttg-3′, Cox2, sense, 5′-caa ctc tat att gct gga aca tgg a
−3′,antisense, 5′-tgg aag cct gtg ata ctt tct gta ct-3′. The
results were analysed using the Real-Time PCR System
(Applied Biosystems). All results were normalized to the
reference gene GAPDH.d IL-12 release. LPS stimulates the TLR4-mediated activation of the
T inhibits the production of IL-12 by Gαi-mediated inhibition of
of PI3 kinase and JNK activation. PMT is shown with its N-terminal
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Statistical significance was assessed by using student’s t
test with *P < 0.05 and **P < 0.01.
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